Ispectamab

• UNSPSC Description:

  Ispectamab is an anti-TNFRSF17 human IgG1 κ monoclonal antibody[1]. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

• Target Antigen:

  TNF Receptor

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Apoptosis

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ispectamab.html

• References & Citations:

  [1]Ispectamab

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported